The worldwide CAR T-cell therapy market is experiencing significant growth, driven by increasing demand for cutting-edge cancer treatment options. This rapid expansion is fueled by contributing forces such as the authorization of CAR T-cell therapies for diverse conditions, advancements in production technologies, and expanding research and develop